Author: admin
-
Randomized controlled trial approved by IRB
oVRcome has received IRB approval of our study to investigate the ability of virtual reality to function as a novel distraction intervention and improve the experience of patients who are receiving chemotherapy in the infusion clinic. The study will deploy and evaluate VR as an intervention for stress, pain, and negative affect in a cohort…
-
Student story featured on Vanderbilt’s website
Recently, founders Alex and Shubham were featured on Vanderbilt’s website for their work with oVRcome! Check out the article here, which discusses the inspiration for oVRcome and how the organization was established.
-
Our Mission
Part 1: Mission Statement oVRcome is an organization that seeks to provide outpatient infusion clinic patients with the opportunity to experience virtual reality as a source of entertainment, distraction, and stress relief. Part 2: Problem Description On average, over 100 patients undergo infusion treatment at the Vanderbilt-Ingram Cancer Center each day. Many of these patients…